You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study

Citation Tools

Article menu

Download PDFPDF

XML
Diabetes and endocrinology
Research
Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Vilar-Gomez E, Athinarayanan SJ, Adams RN, et al
Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study
BMJ Open 2019;9:e023597. doi: 10.1136/bmjopen-2018-023597